Goal-Directed Fluid Therapy in Patients Undergoing Lower Limb Surgeries
Launched by ZAGAZIG UNIVERSITY · Nov 10, 2023
Trial Information
Current as of August 20, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how the amount of fluids given to patients during and after lower limb surgeries can affect their recovery. Researchers want to find out if controlling fluid levels can help patients feel better and recover faster after surgery. The trial is not yet recruiting participants, but it will focus on adults aged 21 to 65 who are planning to have elective surgeries on their legs using spinal anesthesia.
To be eligible for the trial, patients should have a body mass index (BMI) of less than 35 and be in good health (classified as ASA Class I or II, which means they have minimal to no health issues). However, individuals with serious kidney, liver, respiratory, or heart diseases, or who cannot have spinal anesthesia, won't be able to participate. If you decide to take part, you can expect to receive personalized care regarding your fluid intake during the surgery, which may lead to better outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient's acceptance.
- • Patients planned for elective lower limb surgery under spinal anesthesia.
- • Both sexes
- • Body Mass Index(BMI): \<35
- • Age: 21 \~ 65 years
- • American Society of Anesthesiologists(ASA) Physical Status Classification System: Class I \& II
- • Duration of surgery 2\~3 hours
- Exclusion Criteria:
- • Advanced kidney, liver, respiratory or cardiovascular disease.
- • Contraindication for spinal anesthesia.
- • Patients shifted to general anesthesia for any reason.
About Zagazig University
Zagazig University, a prominent educational and research institution located in Egypt, plays a pivotal role in advancing medical knowledge and promoting health innovations through its clinical trials. With a commitment to excellence in research, the university leverages its diverse expertise and state-of-the-art facilities to conduct rigorous clinical studies that aim to improve patient care and outcomes. By fostering collaboration among multidisciplinary teams, Zagazig University contributes significantly to the global medical community, ensuring that its clinical trials adhere to the highest ethical standards and regulatory requirements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Mahmoud Abdelkader, MBBCh
Principal Investigator
Anesthesia, Intensive Care and Pain Management department, Faculty of Medicine, Zagazig University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported